- ½ÒʾÁܰ͹ܻîÐÔÓëÆ¤·ô½¡¿µµÄ¹ØÏµÒÔ¼°·¢½ÍÈ˲γɷֶԸÄÉÆÆ¤·ôÁܰͻîÐԵĿÉÄÜÐÔ
°®ÜÔÀò̫ƽÑóÓ뺫¹ú¸ßÀö´óѧ»úе¹¤³Ìϵͨ¹ý¹²Í¬Ñо¿£¬Ê״νÒʾÁËÁܰ͹ܻîÐÔ¶ÔÆ¤·ô½¡¿µµÄÓ°ÏìÒÔ¼°·¢½ÍÈ˲γɷָÄÉÆÆ¤·ôÁܰͻîÐԵĿÉÄÜÐÔ¡£ÀûÓÃоƬʵÑéÊÒ£¨Lab-on-a-chip£©¼¼Êõ£¬Ñо¿Æ¤·ôÀÏ»¯ºÍÎÈ̬ά³Ö·½ÃæÌṩÁËȫеĿÉÄÜÐÔ£¬ÔÚ¹ú¼ÊѧÊõÆÚ¿¯¡¶NPGÑÇÖÞ²ÄÁÏ£¨NPG Asia Materials£©¡·ÉÏ·¢±íÁËÏà¹ØµÄÑо¿½á¹û¡££¨ÂÛÎÄÃû³Æ£ºThe advanced 3D lymphatic system for assaying the human cutaneous lymphangiogenesis in the microfluidic platform)
ÁܰÍϵͳ£¨Lymphatic system£©Í¨¹ýÑ»·ÅųýÌåÄÚ²úÉúµÄ¸÷ÖÖ·ÏÎÊÇά³ÖÈËÌåÎÈ̬¼¤»îÃâÒßϵͳµÄÖØÒªÆ÷¹Ù¡£Æ¤·ôÁìÓòÒ²Èç´Ë£¬Èç¹ûÁܰÍϵͳѻ·²»³©Í¨£¬ÔòÓпÉÄÜÒý·¢³¤¶»ºÍ¼ÓËÙÆ¤·ôÀÏ»¯¡£µ«Ò»Ö±ÒÔÀ´£¬Ö±½Ó¹Û²ì´¦ÓÚÉúÎïÌ寤·ô×îÉî´¦µÄÁܰÍϵͳµÄ±ä»¯´æÔÚÖî¶àÏÞÖÆ¡£°®ÜÔÀò̫ƽÑóR&IÖÐÐĺ͸ßÀö´óѧ»úе¹¤³ÌϵµÄChung Seok½ÌÊÚʵÑéÊÒ½øÐÐÁ˳¤ÆÚµÄ¹²Í¬Ñо¿£¬Á¦Í¼½ÒʾÁܰÍÑ»·ÓëÆ¤·ôÖ®¼äÏศÏà³ÉµÄÒò¹û¹ØÏµ¡£
¹²Í¬Ñо¿ÍŶӲÉÓÃÁË×îеÄÈËÌ寤·ô½á¹¹¾ßÏÖ¼¼Êõ£¬ÒÔ¼°¿ÉÒÔÈ·È϶à¸öϸ°û¼äÍøÂçµÄÀàÆ÷¹Ù£¨organoid£©¼¼ÊõÖ®Ò»µÄоƬʵÑéÊÒ£¨Lab-on-a-chip£©ÏµÍ³¡£ÔÚÏà¹ØÑо¿ÖУ¬²ÉÓÃÒÔ×î¼ÑÌõ¼þ¹²Í¬ÅàÑøÀ´×ÔÈËÌåµÄƤ·ôϸ°ûºÍÈýάÁܰ͹ÜÐγÉϸ°ûµÄ·½·¨ÖÆ×÷³öÁËÆ¤·ôÁܰÍоƬ£¨SkinLymph-on-a-chip£©¡£Í¨¹ýÕâÖÖ·½Ê½ÊµÏÖÁËÈËÌ寤·ôºÍÁܰ͹ÜÖ®¼äµÄÍøÂ磬Äܹ»Ö±¹ÛµØÈ·ÈÏͨ¹ýƤ·ô²úÉú×÷ÓõÄÎïÖʶÔÁܰ͹ܵÄÐγɺͻîÐÔÔì³ÉµÄÓ°Ïì¡£
ͨ¹ý¾ßÏÖÈËÌ寤·ôºÍÁܰͼäÍøÂçµÄϵͳ£¬¿ÉÒÔÖ±½Ó¹Û²ìͨ¹ýƤ·ô²úÉú×÷ÓõÄÎïÖʶÔÁܰ͹ÜÐγɵÄÓ°Ï죬²¢ÇÒÄܹ»È·ÈÏÉúÎïѧ·½ÃæµÄ·Ö×ӱ仯¡£°®ÜÔÀò̫ƽÑó¾¹ýÓÉ×ÔÈ»·¢½Í500СʱµÄÈ˲ÎÖÆ³ÉµÄLymphanaxTM³É·ÖŨËõÁËÁܰ͹ܻîÐÔ³É·ÖÆßÒ¶µ¨ÜÕXVII£¨Gypenoside XVII£©£¬ÆäÓÐÖúÇ¿»¯Æ¤·ôÆÁÕϺÍÁÜ°ÍµÈÆ¤·ôÄÚ²¿Ñ»·µÄЧ¹ûÔÚÆ¤·ôÁܰÍоƬϵͳÖеõ½ÁËÈ·ÈÏ¡£¹²Í¬Ñо¿ÍŶÓͨ¹ýAIËã·¨µÈ¶îÍâµÄ·ÖÎö½á¹ûµÃ³öÁ˽áÂÛ£¬LymphanaxTMÓÐÖúƤ·ôÄÚÁܰ͹ܵÄÉú³É£¬ËÜÔ콡¿µµÄÁܰ͹ܣ¬´Ó¶øÆðµ½ÔöǿƤ·ôÆÁÕϵÄ×÷Óá£
°®ÜÔÀò̫ƽÑóR&IÖÐÐÄÔº³¤Byung-Fhy Suh±íʾ£º¡°Í¨¹ýÕâÏîÑо¿£¬Ê״νÒʾÁËÈËÌ寤·ôºÍÁܰ͹ÜÖ®¼äµÄ¹ØÏµ£¬ÓÈÆäÊǰ®ÜÔÀò̫ƽÑ󳤯ÚÑо¿µÄÈ˲γɷֹ¦Ð§µÃµ½ÁËÈ·ÈÏ£¬ÒâÒå·Ç·²¡£»ùÓÚÕâÏîÑо¿È¡µÃµÄƤ·ôÉúÎïÁìÓòµÄ³É¹û£¬°®ÜÔÀò̫ƽÑó½ñºóÒ²»á¼ÌÐøÅ¬Á¦Ìṩ´´Ð½â¾ö·½°¸£¬ÖÂÁ¦ÓÚÔ츣ȫÇò¹Ë¿ÍµÄ½¡¿µºÍÃÀÀö¡£¡±ÁíÍ⣬ͨ¹ý´ËÏîÑо¿È·ÈÏÁ˹¦Ð§µÄLymphanaxTMĿǰÒÑÓÃÓÚÑ©»¨ÐãÆ·ÅÆµÄºËÐijɷ֡£















